Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 28,051 |
|
|||||
| News | - | ||||||
| Day High | 2.41 | Low High |
|||||
| Day Low | 2.27 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aditxt Inc | ADTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.10 | 4.41% | 2.37 | 18:49:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.41 | 2.27 | 2.41 | 2.37 | 2.27 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 250 | 28,051 | $ 2.37 | $ 66,412 | - | 2.14 - 68.08 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:04:46 | 1 | $ 2.29 | USD |
Aditxt Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.83M | 1.67M | - | 934k | -27.65M | -16.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aditxt News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.40 | 2.55 | 2.14 | 2.32 | 39,432 | -0.03 | -1.25% |
| 1 Month | 3.19 | 5.09 | 2.14 | 3.32 | 822,051 | -0.82 | -25.71% |
| 3 Months | 3.85 | 5.09 | 2.14 | 3.40 | 329,817 | -1.48 | -38.44% |
| 6 Months | 8.22 | 9.50 | 2.14 | 5.42 | 831,381 | -5.85 | -71.17% |
| 1 Year | 29.416 | 68.08 | 2.14 | 10.44 | 596,502 | -27.05 | -91.94% |
| 3 Years | 105.60 | 1,139.60 | 2.14 | 49.06 | 2,270,120 | -103.23 | -97.76% |
| 5 Years | 211.20 | 1,139.60 | 2.14 | 72.66 | 2,214,266 | -208.83 | -98.88% |
Aditxt Description
| Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. |
